BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35163016)

  • 1. Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia.
    Akimova E; Gassner FJ; Greil R; Zaborsky N; Geisberger R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples.
    Riley DR; Sieber KB; Robinson KM; White JR; Ganesan A; Nourbakhsh S; Dunning Hotopp JC
    PLoS Comput Biol; 2013; 9(6):e1003107. PubMed ID: 23840181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data.
    Robinson KM; Crabtree J; Mattick JS; Anderson KE; Dunning Hotopp JC
    Microbiome; 2017 Jan; 5(1):9. PubMed ID: 28118849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.
    Koski T; Karhu R; Visakorpi T; Vilpo L; Knuutila S; Vilpo J
    Eur J Haematol; 2000 Jul; 65(1):32-9. PubMed ID: 10914937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.
    Saddler C; Ouillette P; Kujawski L; Shangary S; Talpaz M; Kaminski M; Erba H; Shedden K; Wang S; Malek SN
    Blood; 2008 Feb; 111(3):1584-93. PubMed ID: 17971485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
    Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving understanding of the CLL genome.
    Gruber M; Wu CJ
    Semin Hematol; 2014 Jul; 51(3):177-87. PubMed ID: 25048782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic features of B-cell chronic lymphocytic leukemia.
    Stilgenbauer S; Lichter P; Döhner H
    Rev Clin Exp Hematol; 2000 Mar; 4(1):48-72. PubMed ID: 11486330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.
    Hensel M; Zoz M; Giesecke C; Benner A; Neben K; Jauch A; Stilgenbauer S; Ho AD; Krämer A
    Int J Cancer; 2007 Sep; 121(5):978-83. PubMed ID: 17417785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.
    Malek SN
    Oncogene; 2013 Jun; 32(23):2805-17. PubMed ID: 23001040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants.
    Laurie CC; Laurie CA; Smoley SA; Carlson EE; Flinn I; Fridley BL; Greisman HA; Gribben JG; Jelinek DF; Nelson SC; Paietta E; Schaid D; Sun Z; Tallman MS; Weinshilboum R; Kay NE; Shanafelt TD
    Cancer Genet; 2014; 207(1-2):19-30. PubMed ID: 24613276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
    Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
    Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
    Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
    BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of chromosomal abnormalities in chronic lymphocytic leukemia.
    Gahrton G; Juliusson G; Robèrt KH; Friberg K
    Blood Rev; 1987 Sep; 1(3):183-92. PubMed ID: 3332102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia.
    Quijada-Álamo M; Hernández-Sánchez M; Robledo C; Hernández-Sánchez JM; Benito R; Montaño A; Rodríguez-Vicente AE; Quwaider D; Martín AÁ; García-Álvarez M; Vidal-Manceñido MJ; Ferrer-Garrido G; Delgado-Beltrán MP; Galende J; Rodríguez JN; Martín-Núñez G; Alonso JM; García de Coca A; Queizán JA; Sierra M; Aguilar C; Kohlmann A; Hernández JÁ; González M; Hernández-Rivas JM
    J Hematol Oncol; 2017 Apr; 10(1):83. PubMed ID: 28399885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
    Stilgenbauer S; Sander S; Bullinger L; Benner A; Leupolt E; Winkler D; Kröber A; Kienle D; Lichter P; Döhner H
    Haematologica; 2007 Sep; 92(9):1242-5. PubMed ID: 17666364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the pathogenesis of chronic lymphocytic leukemia.
    Klein U; Dalla-Favera R
    Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.